is wegovy a glp-1 drug Novo's becomes first approved for MASH A new wave of weight-loss
Description
And that number could just continue to rise as more drugs come onto the market
Currently in research and development are several small molecule nonpeptide oral GLP-1 agonists that have positive human research results
Endoscopic evaluation and treatment of postoperative bariatric surgery complications
PMID 1326760
Regular follow-up appointments are essential during GLP-1 therapy, typically aligning with the medication's titration schedule (often every 4 weeks initially) and as clinically indicated
Patients on Tirzepatide are already losing 20% of their body weight
